<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | David Knowles | Activity</title>
	<link>https://www.catswannabecats.com/members/peacesinger15/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/peacesinger15/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for David Knowles.</description>
	<lastBuildDate>Sat, 27 Jun 2026 07:28:19 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">8acf7fdf42645a2b65491f34fe1ca5dc</guid>
				<title>David Knowles posted an update: Hepatitis A virus (HAV) infections continue to represent a [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/24535/</link>
				<pubDate>Sun, 08 Jun 2025 12:55:06 -0400</pubDate>

									<content:encoded><![CDATA[<p>Hepatitis A virus (HAV) infections continue to represent a significant disease burden causing approximately 200 million infections, 30 million symptomatic illnesses and 30,000 deaths each year. Effective and safe hepatitis A vaccines have been available since the early 1990s. <a href="https://www.selleckchem.com/products/otssp167.html" rel="nofollow ugc">Selleckchem OTSSP167</a> Initially developed for individual prophylaxis, HAV&hellip;<span class="activity-read-more" id="activity-read-more-24535"><a href="https://www.catswannabecats.com/activity/p/24535/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0850e616f537bd24956b1854f72d3e97</guid>
				<title>David Knowles posted an update: In each patient with aphasia, deficits in more than one [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22612/</link>
				<pubDate>Sat, 07 Jun 2025 12:59:36 -0400</pubDate>

									<content:encoded><![CDATA[<p>In each patient with aphasia, deficits in more than one subtest were observed. The within and between population-groups logistic mixed regression analyses identified significant impairments in processing syntactic complexity at the verb and sentence levels. These findings indicate that the NAVS-G and NAT-G have potential for testing grammatical&hellip;<span class="activity-read-more" id="activity-read-more-22612"><a href="https://www.catswannabecats.com/activity/p/22612/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5a643a747092559a84d4809d723db1c2</guid>
				<title>David Knowles posted an update: In each patient with aphasia, deficits in more than one [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22536/</link>
				<pubDate>Sat, 07 Jun 2025 12:40:52 -0400</pubDate>

									<content:encoded><![CDATA[<p>In each patient with aphasia, deficits in more than one subtest were observed. The within and between population-groups logistic mixed regression analyses identified significant impairments in processing syntactic complexity at the verb and sentence levels. These findings indicate that the NAVS-G and NAT-G have potential for testing grammatical&hellip;<span class="activity-read-more" id="activity-read-more-22536"><a href="https://www.catswannabecats.com/activity/p/22536/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1feb4f842040b9579f8d947b35250ceb</guid>
				<title>David Knowles posted an update: 54, 95% CI = 0.36-0.79).







 The high discussion rate [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19067/</link>
				<pubDate>Wed, 04 Jun 2025 12:20:24 -0400</pubDate>

									<content:encoded><![CDATA[<p>54, 95% CI = 0.36-0.79).</p>
<p> The high discussion rate may be attributed to increased public awareness of genetic testing and adoption of more inclusive clinical genetic testing guidelines. The findings suggest that efforts to increase public awareness of the utility of genetic testing on personalized cancer risk assessment and cancer&hellip;<span class="activity-read-more" id="activity-read-more-19067"><a href="https://www.catswannabecats.com/activity/p/19067/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4f15e65797b96e751bd72af15d27fee1</guid>
				<title>David Knowles posted an update: 74 kU/L, casein 34.2 kU/L, latex-specific (sp)IgE 0.10 kU/L, [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/4375/</link>
				<pubDate>Sat, 31 May 2025 12:41:38 -0400</pubDate>

									<content:encoded><![CDATA[<p>74 kU/L, casein 34.2 kU/L, latex-specific (sp)IgE 0.10 kU/L, gelatin spIgE less then 0.35 kU/L (normal levels less then 0.35 kU/L; Pharmacia, Uppsala, Sweden). Results revealed lactalbumin hydrolysate as one of the M-VAC ingredients according to the manufacturer&#8217;s package insert. Conclusion In most cases with a cow&#8217;s milk allergy, vaccines are&hellip;<span class="activity-read-more" id="activity-read-more-4375"><a href="https://www.catswannabecats.com/activity/p/4375/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a347d5b04119dcc6acba5259cb9fd205</guid>
				<title>David Knowles became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/4284/</link>
				<pubDate>Sat, 31 May 2025 12:29:24 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>